Responses
E-Poster Presentations
P01 Emerging concepts/novel agents
P01.01 A Phase 1a/1b dose-escalation study of intravenously administered SB 11285 alone and in combination with nivolumab in patients with advanced solid tumors
Compose a Response to This Article
Other responses
No responses have been published for this article.